A carregar...
Pharmacokinetics and Safety of Micafungin in Infants Supported with Extracorporeal Membrane Oxygenation
BACKGROUND: Candida is a leading cause of infection in infants on extracorporeal membrane oxygenation (ECMO). Optimal micafungin dosing is unknown in this population because ECMO can alter drug pharmacokinetics (PK). METHODS: To characterize micafungin PK and safety in infants on ECMO, we conducted...
Na minha lista:
| Publicado no: | Pediatr Infect Dis J |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071122/ https://ncbi.nlm.nih.gov/pubmed/27314826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001268 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|